Emergent Biosolutions(EBS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

EBS Emergent Biosolutions

休市中 10-16 16:00:00 EDT

6.38

-0.80

-11.14%

盘后6.38

+0.000.00%

19:59 EDT

最高6.73	最低6.15	成交量223.78万
今开6.64	昨收7.18	日振幅8.07%
总市值3.27亿	流通市值3.09亿	总股本5,127万
成交额1,442万	换手率4.63%	流通股本4,837万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"EBS","market":"US","secType":"STK","nameCN":"Emergent Biosolutions","latestPrice":6.38,"timestamp":1792180800000,"preClose":7.18,"halted":0,"volume":2237817,"hourTrading":{"tag":"盘后","latestPrice":6.38,"preClose":6.38,"latestTime":"19:59 EDT","volume":2378,"amount":15231.6407,"timestamp":1792195199999,"change":0,"changeRate":0,"amplitude":0.018809},"delay":0,"changeRate":-0.11142061281337046,"floatShares":48372666,"shares":51273336,"eps":-3.386973,"marketStatus":"休市中","change":-0.8,"latestTime":"10-16 16:00:00 EDT","open":6.64,"high":6.73,"low":6.1505,"amount":14418661.094785498,"amplitude":0.08071,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-3.386973,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1792396800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1254456000000,"exchange":"NYSE","adjPreClose":7.18,"preHourTrading":{"tag":"盘前","latestPrice":6.8,"preClose":7.18,"latestTime":"09:29 EDT","volume":33727,"amount":231774.02495589998,"timestamp":1792157392087,"change":-0.38,"changeRate":-0.052925,"amplitude":0.05},"postHourTrading":{"tag":"盘后","latestPrice":6.38,"preClose":6.38,"latestTime":"19:59 EDT","volume":2378,"amount":15231.6407,"timestamp":1792195199999,"change":0,"changeRate":0,"amplitude":0.018809},"volumeRatio":2.9482475744725387,"impliedVol":0.6592,"impliedVolPercentile":0.2629},"requestUrl":"/m/hq/s/EBS","defaultTab":"news","newsList":[{"id":"1178687061","title":"Emergent BioSolutions圆满完成7500万美元优先无担保票据回购","url":"https://stock-news.laohu8.com/highlight/detail?id=1178687061","media":"美股速递","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178687061?lang=zh_cn&edition=full","pubTime":"2026-09-03 19:49","pubTimestamp":1788436160,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions（EBS）今日宣布，已顺利完成总额达7500万美元的优先无担保票据回购计划。这一财务操作标志着该公司在优化资本结构方面迈出了坚实一步。此次回购涉及的是公司此前发行的优先无担保债券，其回购价格及相关条款均符合市场惯例与公司既定策略。通过此举，Emergent BioSolutions不仅有效降低了未来的利息负担，还进一步增强了资产负债表的灵活性。该公司管理层表示，此次回购体现了其对股东价值创造的持续承诺，未来将继续审慎评估各类资本配置机会，以支持核心业务的长期增长与创新。分析人士认为，此举或将对公司短期财务指标产生积极影响，并提升投资者信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EBS","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149776488","title":"Emergent BioSolutions获增购Cyfendus（Av7909）合同修订——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1149776488","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149776488?lang=zh_cn&edition=full","pubTime":"2026-09-02 04:15","pubTimestamp":1788293710,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions（纽交所代码：EBS）于近日向美国证券交易委员会（SEC）提交了一份文件，披露其合同修订情况。\n该修订涉及该公司旗下炭疽疫苗产品Cyfendus（Av7909）的额外采购。根据修订条款，采购方将在原有基础上追加订购更多剂量的Cyfendus。\n这笔增购交易的具体金额和交付时间表尚未在文件中详细披露。公司方面表示，此次合同修改反映了采购方对该疫苗产品的持续需求。\n文件提交后，市场对此消息暂无重大反应。Emergent BioSolutions是一家专注于公共卫生防护领域的生物制药公司，其产品线涵盖炭疽、天花等生物威胁相关疫苗及治疗药物。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EBS","BK4139","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143626034","title":"Emergent BioSolutions 获得长期供应合同：有效期至2029年，附两年续约选择权","url":"https://stock-news.laohu8.com/highlight/detail?id=1143626034","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143626034?lang=zh_cn&edition=full","pubTime":"2026-08-31 19:56","pubTimestamp":1788177374,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions宣布，其长期供应协议自2026年10月1日起正式生效，并将持续至2029年9月30日。这份合同还附带了一项重要条款——在现有期限届满后，可选择续约两年。此举无疑为该公司未来的业务稳定性提供了坚实保障。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","BK4139","EBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169864105","title":"Emergent BioSolutions首季营收达1.561亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1169864105","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169864105?lang=zh_cn&edition=full","pubTime":"2026-05-01 04:47","pubTimestamp":1777582055,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions公布第一季度调整后净利润为1190万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","BK4139","EBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191409964","title":"Emergent BioSolutions获新加坡卫生科学局批准扩大Acam2000®适应症至猴痘","url":"https://stock-news.laohu8.com/highlight/detail?id=1191409964","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191409964?lang=zh_cn&edition=full","pubTime":"2026-04-30 19:56","pubTimestamp":1777550192,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions宣布，新加坡卫生科学局已批准扩大其Acam2000®（天花和猴痘（痘苗）活疫苗）的适应症范围，将猴痘预防纳入其中。此次批准标志着该疫苗在亚太地区传染病防控领域取得重要进展。\nAcam2000®作为新一代天花疫苗，此次适应症扩展将强化全球应对猴痘疫情的疫苗储备体系。该公司表示，这一监管批准将有助于提升亚太地区对正痘病毒属疾病的防控能力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","EBS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170248288","title":"Emergent BioSolutions与SAB Biotherapeutics达成协议 将提供端到端开发与制造服务","url":"https://stock-news.laohu8.com/highlight/detail?id=1170248288","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170248288?lang=zh_cn&edition=full","pubTime":"2026-04-29 19:37","pubTimestamp":1777462666,"startTime":"0","endTime":"0","summary":"根据协议条款，Emergent BioSolutions将为SAB Biotherapeutics提供涵盖从研发到生产的全流程服务。此次合作将充分发挥Emergent在生物制药领域的技术专长和制造能力。\n两家公司此次达成的战略合作，标志着在生物制药外包服务领域的深度整合。通过这项端到端服务协议，SAB Biotherapeutics有望加速其创新疗法的开发进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","BK4139","SABS","EBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184841750","title":"Emergent BioSolutions与SAB Biotherapeutics达成长期战略生产协议 共同推进1型糖尿病候选药物SAB-142","url":"https://stock-news.laohu8.com/highlight/detail?id=1184841750","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1184841750?lang=zh_cn&edition=full","pubTime":"2026-04-29 19:35","pubTimestamp":1777462515,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions与SAB Biotherapeutics, Inc.正式签署长期战略生产合作协议，双方将携手推进针对1型糖尿病的候选药物SAB-142的研发进程。这项合作标志着两家生物技术企业在糖尿病治疗领域迈出重要一步，通过整合双方在生物制药生产与技术研发方面的专业优势，为SAB-142的临床开发与未来商业化生产提供坚实保障。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EBS","BK4583","SABS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173150485","title":"Emergent BioSolutions坎顿工厂将生产原料药并获独家分销权","url":"https://stock-news.laohu8.com/highlight/detail?id=1173150485","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173150485?lang=zh_cn&edition=full","pubTime":"2026-04-28 20:05","pubTimestamp":1777377936,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions公司宣布，其坎顿生产基地将启动原料药生产业务，并同步获得相关产品的独家分销权限。这一战略布局将强化该公司在生物制药领域的供应链控制力与市场影响力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EBS","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518822412","title":"Emergent Biosolutions Inc.盘中异动 早盘快速下跌5.20%报5.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518822412","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518822412?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:35","pubTimestamp":1741613729,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时35分，Emergent Biosolutions Inc.股票出现波动，股价大幅跳水5.20%。截至发稿，该股报5.47美元/股，成交量5.3544万股，换手率0.10%，振幅1.56%。Emergent Biosolutions Inc.股票所在的制药行业中，整体跌幅为0.64%。其相关个股中，Sonoma Pharmaceuticals, Inc.、Alpha Teknova, Inc.、Flora Growth Corp.涨幅较大，Sonoma Pharmaceuticals, Inc.、Petros Pharmaceuticals, Inc.、苏轩堂较为活跃，换手率分别为52.14%、8.77%、2.85%，振幅较大的相关个股有Shuttle Pharmaceuticals Holdings, Inc.、惠普森医药、Alpha Teknova, Inc.，振幅分别为13.84%、12.67%、12.14%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213529a26a2645&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213529a26a2645&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4583","BK4139","EBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516677553","title":"Emergent Biosolutions Inc.股价重挫15.96% 市值跌4963.83万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677553","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516677553?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:32","pubTimestamp":1741098779,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时32分，Emergent Biosolutions Inc.股票出现异动，股价快速下跌15.96%。截至发稿，该股报5.74美元/股，成交量35.3898万股，换手率0.65%，振幅4.39%。Emergent Biosolutions Inc.股票所在的制药行业中，整体跌幅为0.02%。Emergent Biosolutions Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223259abe7f004&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223259abe7f004&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4583","BK4139","EBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516966912","title":"Emergent BioSolutions(EBS.US)：2024年Q4财报实现营收1.947亿美元，前值为2.766亿美元，预期值为2.547亿美元；每股收益为0.05美元，前值为-0.77美元，预期值为-0.50美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516966912","media":"金融界","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516966912?lang=zh_cn&edition=full","pubTime":"2025-03-04 05:32","pubTimestamp":1741037576,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions(EBS.US)：2024年Q4财报实现营收1.947亿美元，前值为2.766亿美元，预期值为2.547亿美元；每股收益为0.05美元，前值为-0.77美元，预期值为-0.50美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/04053248499197.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["EBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101283831","title":"Emergent BioSolutions第四季度调整后每股收益$0.05，超出预期$(0.49)，销售额$194.70M不及预期$254.67M","url":"https://stock-news.laohu8.com/highlight/detail?id=1101283831","media":"财报速递","labels":["merge","express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1101283831?lang=zh_cn&edition=full","pubTime":"2025-03-04 05:31","pubTimestamp":1741037470,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions报告的季度每股收益为$0.05，比分析师预期的$高出110.2%。公司报告的季度销售额为$194.70M，不及分析师预期的$254.67M，低23.55%。这比去年同期的销售额$276.60M减少了29.61%。以上内容来自Benzinga Earnings专栏，原文如下：Emergent BioSolutions  reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $ by 110.2 percent. This is a 106.49 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $194.70 million which missed the analyst consensus estimate of $254.67 mi","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Emergent BioSolutions第四季度调整后每股收益$0.05，超出预期$(0.49)，销售额$194.70M不及预期$254.67M","news_tag":"merge,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516765030","title":"Emergent Biosolutions Inc.盘中异动 下午盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516765030","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516765030?lang=zh_cn&edition=full","pubTime":"2025-03-04 03:28","pubTimestamp":1741030121,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日03时28分，Emergent Biosolutions Inc.股票出现异动，股价快速下跌5.01%。截至发稿，该股报7.11美元/股，成交量86.0413万股，换手率1.59%，振幅6.63%。Emergent Biosolutions Inc.股票所在的制药行业中，整体涨幅为1.03%。Emergent Biosolutions Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304032841a25d920f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304032841a25d920f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4583","BK4139","EBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516237176","title":"Emergent Biosolutions Inc.盘中异动 临近午盘股价大涨5.10%报7.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516237176","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516237176?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:48","pubTimestamp":1740761281,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日00时48分，Emergent Biosolutions Inc.股票出现异动，股价快速拉升5.10%。截至发稿，该股报7.42美元/股，成交量25.5917万股，换手率0.47%，振幅6.37%。Emergent Biosolutions Inc.股票所在的制药行业中，整体跌幅为0.10%。Emergent Biosolutions Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010048019634390c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010048019634390c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EBS","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513781327","title":"Emergent Biosolutions Inc.盘中异动 急速跳水5.19%报7.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513781327","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513781327?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:28","pubTimestamp":1740410881,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时28分，Emergent Biosolutions Inc.股票出现异动，股价大幅下挫5.19%。截至发稿，该股报7.31美元/股，成交量32.9475万股，换手率0.61%，振幅4.86%。Emergent Biosolutions Inc.股票所在的制药行业中，整体涨幅为0.75%。Emergent Biosolutions Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242328039891035c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242328039891035c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EBS","BK4139","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512489924","title":"Emergent Biosolutions Inc.盘中异动 大幅下跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512489924","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512489924?lang=zh_cn&edition=full","pubTime":"2025-02-19 23:31","pubTimestamp":1739979095,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日23时31分，Emergent Biosolutions Inc.股票出现异动，股价急速下跌5.16%。截至发稿，该股报7.91美元/股，成交量48.0852万股，换手率0.89%，振幅4.44%。Emergent Biosolutions Inc.股票所在的制药行业中，整体涨幅为0.87%。其相关个股中，坎伯兰药业、Gelteq Limited、和黄医药涨幅较大，Petros Pharmaceuticals, Inc.、Painreform Ltd.、大自然药业较为活跃，换手率分别为36.19%、29.93%、8.63%，振幅较大的相关个股有坎伯兰药业、Painreform Ltd.、Medicus Pharma Ltd.，振幅分别为12.24%、10.24%、9.60%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219233135a24c07b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219233135a24c07b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EBS","BK4139","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512193283","title":"Emergent Biosolutions Inc.盘中异动 下午盘大幅跳水5.14%报9.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512193283","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512193283?lang=zh_cn&edition=full","pubTime":"2025-02-19 02:14","pubTimestamp":1739902489,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日02时14分，Emergent Biosolutions Inc.股票出现异动，股价快速下挫5.14%。截至发稿，该股报9.22美元/股，成交量49.1939万股，换手率0.91%，振幅6.77%。Emergent Biosolutions Inc.股票所在的制药行业中，整体涨幅为1.91%。其相关个股中，Painreform Ltd.、Flora Growth Corp.、Indivior Plc涨幅较大，Painreform Ltd.、Petros Pharmaceuticals, Inc.、Cbdmd, Inc.较为活跃，换手率分别为4824.40%、234.00%、12.63%，振幅较大的相关个股有Painreform Ltd.、Cyclo Therapeutics Inc C/Wts 11/12/2025、Sunshine Biopharma Inc C/Wts ，振幅分别为74.44%、35.46%、25.64%。Emergent Biosolutions Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219021449a24adb7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219021449a24adb7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EBS","BK4139","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510300913","title":"Emergent Biosolutions Inc.盘中异动 大幅下跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510300913","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510300913?lang=zh_cn&edition=full","pubTime":"2025-02-12 01:46","pubTimestamp":1739296006,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日01时46分，Emergent Biosolutions Inc.股票出现波动，股价快速下挫5.14%。截至发稿，该股报9.59美元/股，成交量46.3047万股，换手率0.85%，振幅5.19%。Emergent Biosolutions Inc.股票所在的制药行业中，整体跌幅为0.04%。其相关个股中，Scilex Holding Company C/Wts 10/11/2027 、Cyclo Therapeutics Inc C/Wts 11/12/2025、坎伯兰药业涨幅较大，大自然药业、Quantum Biopharma Ltd.、Cbdmd, Inc.较为活跃，换手率分别为33.46%、26.74%、7.09%，振幅较大的相关个股有Cyclo Therapeutics Inc C/Wts 11/12/2025、Quantum Biopharma Ltd.、Alvotech C/Wts ，振幅分别为20.30%、17.55%、15.91%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212014647abcb2fff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212014647abcb2fff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4583","EBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509773574","title":"Emergent Biosolutions Inc.盘中异动 股价大跌5.16%报9.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509773574","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509773574?lang=zh_cn&edition=full","pubTime":"2025-02-08 03:27","pubTimestamp":1738956457,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日03时27分，Emergent Biosolutions Inc.股票出现波动，股价快速下跌5.16%。截至发稿，该股报9.92美元/股，成交量51.1397万股，换手率0.94%，振幅5.64%。Emergent Biosolutions Inc.股票所在的制药行业中，整体涨幅为0.55%。Emergent Biosolutions Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208032737987ddf5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208032737987ddf5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4583","EBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508149777","title":"Emergent Biosolutions Inc.盘中异动 快速跳水8.03%报10.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508149777","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508149777?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:35","pubTimestamp":1738593312,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时35分，Emergent Biosolutions Inc.股票出现异动，股价急速下挫8.03%。截至发稿，该股报10.35美元/股，成交量18.2814万股，换手率0.34%，振幅3.45%。Emergent Biosolutions Inc.股票所在的制药行业中，整体跌幅为0.13%。其相关个股中，Medicus Pharma Ltd.、脑再生科技、Incannex Healthcare Inc.涨幅较大，Inmed Pharmaceuticals Inc.、Painreform Ltd.、苏轩堂较为活跃，换手率分别为29.19%、4.18%、1.59%，振幅较大的相关个股有Ironwood医药、Procaps Group, S.A.、Canopy Growth Corporation，振幅分别为6.84%、5.66%、5.53%。Emergent Biosolutions Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223512a2380a79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223512a2380a79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4583","EBS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.emergentbiosolutions.com","stockEarnings":[{"period":"1week","weight":-0.0963},{"period":"1month","weight":-0.0548},{"period":"3month","weight":-0.1638},{"period":"6month","weight":-0.2758},{"period":"1year","weight":-0.3213},{"period":"ytd","weight":-0.4838}],"compareEarnings":[{"period":"1week","weight":-0.0197},{"period":"1month","weight":0.0122},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.0748},{"period":"1year","weight":0.1553},{"period":"ytd","weight":0.1193}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Emergent Biosolutions Inc.于1998年5月在美国密歇根州成立，随后在 2004年6月改为特拉华公司。公司拥有两个经营部门：生物防卫和生物科学。该公司是一家全球性生命科学公司，专注于提供创新的准备和响应解决方案，以应对意外、故意和自然发生的公共健康威胁。","yearOnYearQuotes":[{"month":1,"riseRate":0.7,"avgChangeRate":0.042008},{"month":2,"riseRate":0.4,"avgChangeRate":-0.01419},{"month":3,"riseRate":0.45,"avgChangeRate":-0.032712},{"month":4,"riseRate":0.45,"avgChangeRate":-0.034251},{"month":5,"riseRate":0.6,"avgChangeRate":0.111052},{"month":6,"riseRate":0.6,"avgChangeRate":0.007243},{"month":7,"riseRate":0.55,"avgChangeRate":0.094079},{"month":8,"riseRate":0.45,"avgChangeRate":-0.024659},{"month":9,"riseRate":0.4,"avgChangeRate":-0.028687},{"month":10,"riseRate":0.55,"avgChangeRate":0.026438},{"month":11,"riseRate":0.578947,"avgChangeRate":-0.002144},{"month":12,"riseRate":0.6,"avgChangeRate":0.044099}],"exchange":"NYSE","name":"Emergent Biosolutions","nameEN":"Emergent BioSolutions"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Emergent Biosolutions(EBS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Emergent Biosolutions(EBS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Emergent Biosolutions,EBS,Emergent Biosolutions股票,Emergent Biosolutions股票老虎,Emergent Biosolutions股票老虎国际,Emergent Biosolutions行情,Emergent Biosolutions股票行情,Emergent Biosolutions股价,Emergent Biosolutions股市,Emergent Biosolutions股票价格,Emergent Biosolutions股票交易,Emergent Biosolutions股票购买,Emergent Biosolutions股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Emergent Biosolutions(EBS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Emergent Biosolutions(EBS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}